Dr. O'Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-255-3125
Education & Training
University College of Dublin National Univ SOMClass of 2005
Certifications & Licensure
MN State Medical License 2016 - 2025
DC State Medical License 2013 - 2016
Clinical Trials
- Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy Start of enrollment: 2017 Nov 13
- T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial Start of enrollment: 2021 Jan 06
Publications & Presentations
PubMed
- 92 citationsEvolving standards of care and new challenges in the management of HER2-positive breast cancer.Grace M. Choong, Grace D. Cullen, Ciara C. O’Sullivan
CA. 2020-09-01 - 22 citationsANG1005 for breast cancer brain metastases: correlation between 18 F-FLT–PET after first cycle and MRI in response assessmentCiara C. O’Sullivan, Maria Liza Lindenberg, Christine Bryla, N. Patronas, Cody J. Peer
Breast Cancer Research and Treatment. 2016-09-12 - 70 citationsThe VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical CancerCiara C. O’Sullivan, Maureen Edgerly, Margarita Velarde, Julia Wilkerson, Aradhana M. Venkatesan
The Journal of Clinical Endocrinology and Metabolism. 2014-01-03
Press Mentions
Adjuvant Trastuzumab Benefit Elucidated in Small HER2-Positive Breast CancerAugust 28th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
